Neo4j for Translational Intelligence: Connecting Biomarkers, Targets and Clinical Evidence

NODES 2026 Agenda

Neo4j for Translational Intelligence: Connecting Biomarkers, Targets and Clinical Evidence

Session track: AI Engineering

Session time: 04:30 pm - 05:00 pm UTC November 12

Session description:

This talk explores how D&A MedLabs uses Neo4j to create a biomedical intelligence platform connecting molecular biology, drug discovery, clinical trials, toxicology, pharmacovigilance, and scientific literature into a unified graph ecosystem. We will demonstrate how graph databases and AI agents can help researchers navigate complex biomedical networks to uncover hidden relationships, prioritize biomarkers and drug targets, and generate actionable insights.

Speaker

Malick Paye

Founder, D&A MedLabs

Malick Paye is the CEO and founder of D&A MedLabs, an AI startup building graph-native biomedical intelligence platforms for translational research and drug discovery. He brings over 20 years of experience in data science, AI, and healthcare innovation, including 10 years at bioMérieux as a Technical Lead in Machine Learning, 5 years at L'Oréal as a Data Science Program Manager, and 6 years at Sodexo leading Data Science at the group level. His expertise spans knowledge graphs, agentic AI, NLP, and biomedical data integration.